Bài kiểm tra có liên kết hướng dẫn · Trung bình Cấp độ

Bài kiểm tra thiết kế liệu pháp điều trị bằng AI Peptide

Kiểm tra thiết kế tính toán so với bằng chứng điều trị, sự ràng buộc và chức năng, tính ổn định, tính chọn lọc và xác nhận thử nghiệm.

Đường dẫn hướng dẫn liên quanThiết kế trị liệu AI Peptide
Câu hỏi 1 của 8

What does a computationally designed peptide sequence establish?

Xem trước mọi câu hỏi8 câu hỏi

Câu trả lời và giải thích xuất hiện khi bạn làm bài kiểm tra.

  1. What does a computationally designed peptide sequence establish?
    • Proof of target engagement in the body
    • A candidate sequence for experimental testing
    • A clinically effective medicine
    • A safe dose for patients
  2. Why test binding with an independent assay?
    • A predicted interface may not reflect actual experimental binding
    • A structural model proves binding already
    • Independent assays replace biological controls
    • Binding results determine clinical efficacy
  3. Does a peptide binder necessarily alter target function?
    • Yes, all binders inhibit targets
    • Yes, docking scores measure function
    • No, peptides cannot bind proteins
    • No; binding alone does not show agonism, inhibition, or therapeutic effect
  4. Which properties should be checked beyond target binding?
    • Only model confidence
    • Only the target’s name
    • Stability, selectivity, delivery, exposure, and toxicity
    • Only sequence length
  5. Why might a peptide fail despite a strong predicted structure?
    • The model tested toxicity already
    • Its experimental conformation or biological stability may differ
    • Predicted structure guarantees in-vivo exposure
    • A flexible target always binds tightly
  6. Which evidence is needed before describing a candidate as a therapy?
    • One in-vitro binding result
    • A generated amino-acid sequence
    • Evidence progresses through functional, safety, pharmacology, and clinical studies
    • A docking score above a threshold
  7. What information supports reproducibility of peptide experiments?
    • Sequence, modifications, target construct, assay conditions, and model version
    • Only the project title
    • Only the lab’s location
    • Only the predicted structure image
  8. What can AI contribute to peptide development?
    • Replace synthesis and safety studies
    • Guarantee delivery to a tissue
    • Confirm patient benefit from binding
    • Prioritize sequences and explore a design space for later testing